In human estrogen receptor binding tests, enclomiphene had lower affinity than MDL 103,323, which had 5-6 fold greater affinity.
In plain wordsIn lab tests, enclomiphene bound the human estrogen receptor less strongly than MDL 103,323.
- Peptide
- Enclomiphene
- Outcome
- DecreaseEstrogen receptor affinity
- Study
humann: not reported in source
human estrogen receptor- Comparator
- MDL 103,323
- Outcome group
- Receptor activity and mechanism · Pharmacology
- Studied dose
- Dose not stated
Measurements
- Relative affinity
- 5 to 6 fold
- MDL 103,323 versus enclomiphene
Source sentences
MDL 103,323 had 5-6 fold greater affinity for the human estrogen receptor than did either tamoxifen or enclomiphene.